Medicni Perspektivi, an open-access journal published by the Dnipro State Medical University in Ukraine, serves as a valuable platform for disseminating research within the diverse field of medicine. Launched in 2013, this journal has swiftly established itself as a noteworthy contribution to the medical community, with its commitment to accessibility promoting the sharing of knowledge among researchers, healthcare professionals, and students alike. Though currently categorized in the Q4 quartile of Medicine (Miscellaneous), and ranked #472 out of 636 in the Scopus database for General Medicine, Medicni Perspektivi aims to enhance its academic standing and expand its impact over converged years from 2019 to 2024. By providing open access to its articles, the journal fosters a collaborative environment for those interested in the latest medical advancements and research findings, reflecting the dynamic nature of contemporary medical science.

Cardiovascular Therapeutics is a renowned Open Access journal, published by WILEY-HINDAWI, that has been at the forefront of advancing knowledge in the field of cardiology and cardiovascular medicine since its establishment. With a strong commitment to disseminating high-quality research, the journal has successfully positioned itself within the Q2 quartile in multiple categories, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pharmacology. The journal is indexed in Scopus, achieving impressive rankings, such as #95 out of 387 in Cardiology, and #87 out of 272 in Medical Pharmacology. Situated in the United Kingdom, Cardiovascular Therapeutics embraces an Open Access model since 2019, ensuring that groundbreaking research is accessible to researchers, practitioners, and students across the globe. The journal is dedicated to publishing original research articles, reviews, and clinical studies that contribute to the understanding and treatment of cardiovascular diseases, making it an essential resource for those invested in improving patient outcomes and advancing therapeutic strategies in this vital area of medicine.

Acta Medica Portuguesa is a distinguished journal in the field of General Medicine, published by ORDEM MEDICOS. Since its inception, this open-access journal has been a vital platform for disseminating impactful research and reviews in various aspects of medicine, particularly from Portuguese and international perspectives. With an ISSN of 0870-399X and an E-ISSN of 1646-0758, it caters to a global audience and has been open-access since 2003, ensuring maximum reach and visibility of its contributions. Despite its recent Q4 ranking in the Medicine (miscellaneous) category for 2023, it holds a commendable rank of 248 out of 636 in Scopus, indicating a strong percentile standing of 61%. This journal not only chronicles pivotal findings and advances in the medical field but also fosters collaboration and dialogue among researchers, professionals, and students alike. Based in Portugal at AV ALMIRANTE GAGO COUTINHO, 151, LISBON 1749-084, PORTUGAL, Acta Medica Portuguesa continues to contribute significantly to the medical literature landscape, inviting submissions that offer novel insights and enhance medical knowledge.

BMC Sports Science Medicine and Rehabilitation is a leading open-access journal published by BMC, based in the United Kingdom, dedicated to the dissemination of high-quality research in the fields of sports science, medicine, and rehabilitation. Established in 2013, the journal has quickly gained a prominent position, achieving Q2 rankings in major categories such as Orthopedics and Sports Medicine, Physical Therapy, Sports Therapy and Rehabilitation, and Rehabilitation as of 2023. With a Scopus ranking placing it in the 66th percentile for Rehabilitation and the 62nd percentile for Physical Therapy, BMC Sports Science Medicine and Rehabilitation serves as a vital resource for researchers, practitioners, and students alike. Its open-access format ensures that groundbreaking research is freely available, promoting knowledge exchange and fostering advancements in therapeutic practices and sports science innovations. Authors and readers are encouraged to engage with the journal's broad scope, spanning from evidence-based interventions to innovative rehabilitation strategies, all aimed at enhancing human performance and well-being.

Advances in Medical Sciences is a peer-reviewed journal published by Elsevier Urban & Partner Sp. z o.o., dedicated to fostering advancements in the field of medicine and healthcare. Established in 2006, this esteemed journal has become a vital resource for researchers, professionals, and students alike, ranking in the Q2 category for Medicine (Miscellaneous) in 2023 and achieving an impressive 84th percentile in the Scopus rankings for General Medicine, placing it at 99 out of 636 journals. With a focus on publishing high-quality research and comprehensive reviews, this journal serves as a platform for disseminating innovative findings that push the boundaries of medical science. Although open access options are not currently available, the journal's rigorous standards ensure that every published article contributes significantly to the global medical community and promotes the understanding of contemporary medical challenges. Located in Wroclaw, Poland, the journal continues to engage a wide readership, driving forward the dialogue in various facets of medical research.

Diabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

MEDICINE & SCIENCE IN SPORTS & EXERCISE is a premier journal published by Lippincott Williams & Wilkins, dedicated to advancing the fields of sports medicine, exercise physiology, orthopedics, and physical therapy. With a significant history dating back to 1969, this journal provides a critical platform for disseminating cutting-edge research and clinical insights that shape contemporary sports science. Recognized for its rigorous peer-review standards, it boasts an impressive impact factor and ranks in the top quartile (Q1) across pivotal categories including Orthopedics and Sports Medicine, Physical Therapy, and Rehabilitation. Researchers and healthcare professionals will find it an invaluable resource for the latest findings and trends that inform practice and enhance athletic performance. The journal is available in both print and digital formats, ensuring accessibility for its audience worldwide. By fostering a rich dialogue among scientists, practitioners, and students, MEDICINE & SCIENCE IN SPORTS & EXERCISE solidifies its importance in the evolving landscape of sports health and exercise research.

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.